Terlipressin - CISMeF

Preferred Label : Terlipressin;

MeSH definition : An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.;

MeSH synonym : Glycylpressin; TGLVP; Terlypressin; Triglycyl Lysine Vasopressin; Triglycylvasopressin; Glipressin; Glypressin;

MeSH hyponym : Gly-Gly-Gly-8-Lys-vasopressin; Gly Gly Gly 8 Lys vasopressin; N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin; Vasopressin, tri-Gly-8-Lys-; tri-Gly-8-Lys- Vasopressin;

MeSH CAS label : N-(N- (N-glycylglycyl)glycyl)-L-lysinevasopressin;

MeSH Related Number : 14636-12-5 (Terlipressin);

UNII : 7Z5X49W53P;

Details

Origin ID

D000077585;

UMLS CUI

C0145185;

ATC code(s)
- terlipressin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Terlipressin [ICHI extension code]
- Terlipressin Acetate [NCIt concept]
CISMeF manual mappings
- terlipressin [Substance BNPC]
MeSH indexing information
- shock, septic [MeSH Descriptor]
Pharmacological action(s)
- antihypertensive agents [MeSH Descriptor]
- vasoconstrictor agents [MeSH Descriptor]
Record concept(s)
- Triglycyl-(8-lysine)vasopressin [MeSH concept]
- remestyp [MeSH concept]
- terlipressin [MeSH concept]
Related MeSH Supplementary Concept(s)
- terlivaz [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients